Repurgenesis develops an advanced AI platform specifically for drug repurposing. As a multimodal, multi-method, and intelligently orchestrated system, it provides highly reliable and accurate predictions for drug candidates. They work across three main areas:

• Drug Repurposing Innovation: Leveraging deep learning, generative AI, and the PrimeKG knowledge graph to systematically uncover the hidden potential of existing drugs across new disease indications.
• Accelerating Development & Reducing Costs: Shortening the drug repurposing timeline, improving success rates, and lowering R&D costs to make effective therapies more accessible.
• Patient-Centric Approach: Focusing on rare diseases and major unmet medical needs, while actively advancing personalized and precision medicine to ensure patients receive timely and effective treatments.

One of their main drives lies on forming strategic partnerships with key stakeholders across the ecosystem, including biotech and pharmaceutical companies, venture capital, research institutes, and patient groups.